Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Osiris Therapeutics (NASDAQ: OSIR)


Last Updated: Dec-07-2016 20:14:21

OSIR News & Stock Updates

Premium Research

Osiris Therapeutics (NASDAQ: OSIR) Profile

Volume124,500
Open$5.29
Prior Close$5.35
Market Cap$0.18 B
PE Ratio66.88
Beta0.83
OSIRIS THERAPEUTICS INC. is a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory orthopedic and cardiovascular areas. Osiris currently markets and sells Osteocel for regenerating bone in orthopedic indications. Prochymal is being evaluated in Phase III clinical trials for three indications including acute and steroid refractory Graft versus Host Disease and also Crohn's disease and is the only stem cell therapeutic currently designated by FDA as both an Orphan Drug and Fast Track product. Osiris also has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies. Osiris is a fully integrated company having developed capabilities in research development manufacturing marketing and distribution of stem cell products.
SymbolCompanyMarket cap
AMGNAmgen$107.95 B
GILDGilead Sciences Inc$95.48 B
CELGCelgene Corp$91 B
BIIBBiogen Inc Cmn$63.35 B
REGNRegeneron Pharmaceutical$38.91 B
BXLTBaxalta Incorporated Common Sto$31.46 B
ALXNAlexion Pharm Inc$27.84 B
INCYIncyte Corporation$20.2 B
VRTXVertex Pharmaceutic$19.38 B
ILMNIllumina Inc$18.57 B

OSIR Earnings

1st Quarter Earnings$ ()
2nd Quarter Earnings$ ()
3rd Quarter Earnings$ ()
4th Quarter Earnings$ ()
PE Ratio66.88
EPS Growth0%
Recent Earnings$
Annual EPS$0
Market Capitalization$0.18 B
Insider Shareholder %0.446%
Annual Revenue$0 B
Number of Shares Outstanding34,450 Shares
Institutional Shareholder %19.9%
Annual Net Income$0B
TTM Net Profit Margin$100
One Year Return-47.46%
Three Year Return-89.13%
Five Year Return8.44%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$
Annual EPS$0
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD%
PE Ratio66.88
Recent Earnings$
Dividends per Share$
Stock Split Ratio
beta0.83

OSIR Key Stats

Last Price$5.27
Net Change$-0.08 (-1.5%)
Bid$0
Ask Price$0
Open Price$5.29
Previous Close Price$5.35
High Price$5.35
Low Price$5.08
Number of Trades482
Volume124,500
Fifty Two Week High$10.98 (2015-12-17)
Fifty Two Week Low$3.55 (2016-03-16)
Average Daily Volume161,006
Share Outstanding34,450 Shares
Total Dividend Payout$0/yr
Dividend Yield0%